BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12387014)

  • 41. [Insulin secretion: recent acquisitions (author's transl)].
    Malaisse WJ
    Rev Med Brux; 1981 Apr; 2(4):379-84. PubMed ID: 7027399
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Making sense of glucose sensing.
    Efrat S
    Nat Genet; 1997 Nov; 17(3):249-50. PubMed ID: 9354775
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL; Ribes G; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract]   [Full Text] [Related]  

  • 45. Sulphonylureas, magnesium and cardiac K+ ATP channels.
    Matz R
    Diabetologia; 2000 Aug; 43(8):1080-1. PubMed ID: 10990091
    [No Abstract]   [Full Text] [Related]  

  • 46. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ion channel effects of antidiabetic sulfonylureas.
    Lazdunski M
    Horm Metab Res; 1996 Sep; 28(9):488-95. PubMed ID: 8911986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreatic and extrapancreatic sulfonylurea receptors.
    Panten U; Schwanstecher M; Schwanstecher C
    Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 50. [Progress in studies on antidiabetic agents].
    Tang L; Yang YS; Ji RY
    Yao Xue Xue Bao; 2001 Sep; 36(9):711-5. PubMed ID: 12580115
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of beta-cell secretion. Possible involvement of K-ATP channels.
    Faehling M; Ashcroft FM
    Adv Exp Med Biol; 1997; 426():247-52. PubMed ID: 9544281
    [No Abstract]   [Full Text] [Related]  

  • 53. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Priming of insulin granules for exocytosis by granular Cl(-) uptake and acidification.
    Barg S; Huang P; Eliasson L; Nelson DJ; Obermüller S; Rorsman P; Thévenod F; Renström E
    J Cell Sci; 2001 Jun; 114(Pt 11):2145-54. PubMed ID: 11493650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regulation of ATP-dependent potassium channels].
    De Weille JR; Schmid-Antomarchi H; Fosset M; Lazdunski M
    Journ Annu Diabetol Hotel Dieu; 1991; ():119-24. PubMed ID: 1715929
    [No Abstract]   [Full Text] [Related]  

  • 56. Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas.
    Henquin JC
    Biochimie; 2017 Dec; 143():3-9. PubMed ID: 28711685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sulfonylurea receptors].
    Ishihara H; Oka Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():661-5. PubMed ID: 12430300
    [No Abstract]   [Full Text] [Related]  

  • 58. Insulin secretion and differential gene expression in glucose-responsive and -unresponsive MIN6 sublines.
    Minami K; Yano H; Miki T; Nagashima K; Wang CZ; Tanaka H; Miyazaki JI; Seino S
    Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E773-81. PubMed ID: 11001758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulinotropic activity of sulfonylurea/pullulan conjugate in rat islet microcapsule.
    Kim S; Chae SY; Na K; Kim SW; Bae YH
    Biomaterials; 2003 Nov; 24(26):4843-51. PubMed ID: 14530081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint.
    Rorsman P
    Diabetologia; 1997 May; 40(5):487-95. PubMed ID: 9165215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.